Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chagas Disease | 27 | 2026 | 324 | 5.820 |
Why?
|
| Trypanosoma cruzi | 25 | 2026 | 262 | 4.410 |
Why?
|
| Microbiota | 5 | 2026 | 438 | 1.860 |
Why?
|
| Host-Parasite Interactions | 4 | 2026 | 72 | 1.270 |
Why?
|
| Protozoan Vaccines | 3 | 2024 | 100 | 1.030 |
Why?
|
| Ascariasis | 2 | 2024 | 77 | 1.010 |
Why?
|
| Vaccines | 4 | 2024 | 383 | 0.980 |
Why?
|
| RNA, Messenger | 5 | 2025 | 2566 | 0.970 |
Why?
|
| Leishmaniasis | 1 | 2024 | 41 | 0.850 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2026 | 832 | 0.690 |
Why?
|
| Signaling Lymphocytic Activation Molecule Family Member 1 | 1 | 2020 | 6 | 0.660 |
Why?
|
| Macrophages | 2 | 2025 | 659 | 0.650 |
Why?
|
| Parasites | 1 | 2020 | 34 | 0.640 |
Why?
|
| Immunity, Innate | 2 | 2024 | 407 | 0.640 |
Why?
|
| Rhodnius | 2 | 2017 | 2 | 0.630 |
Why?
|
| Transcription, Genetic | 2 | 2024 | 1399 | 0.600 |
Why?
|
| Virulence Factors | 2 | 2023 | 181 | 0.560 |
Why?
|
| DNA, Protozoan | 2 | 2018 | 33 | 0.540 |
Why?
|
| Genetic Heterogeneity | 1 | 2018 | 134 | 0.540 |
Why?
|
| Animals | 30 | 2026 | 33982 | 0.530 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 521 | 0.530 |
Why?
|
| Spike Glycoprotein, Coronavirus | 5 | 2023 | 216 | 0.530 |
Why?
|
| Plant Leaves | 1 | 2017 | 52 | 0.500 |
Why?
|
| Cytokines | 4 | 2026 | 1336 | 0.490 |
Why?
|
| Insect Vectors | 1 | 2017 | 113 | 0.480 |
Why?
|
| Rhodococcus equi | 2 | 2025 | 7 | 0.440 |
Why?
|
| Actinomycetales Infections | 2 | 2025 | 14 | 0.430 |
Why?
|
| Horse Diseases | 2 | 2025 | 35 | 0.430 |
Why?
|
| Immune System | 2 | 2026 | 99 | 0.410 |
Why?
|
| Mice, Inbred BALB C | 9 | 2026 | 975 | 0.410 |
Why?
|
| Cardiomyopathies | 1 | 2018 | 518 | 0.400 |
Why?
|
| Mice | 18 | 2026 | 18268 | 0.390 |
Why?
|
| Chagas Cardiomyopathy | 3 | 2021 | 53 | 0.360 |
Why?
|
| Adjuvants, Immunologic | 2 | 2024 | 391 | 0.350 |
Why?
|
| Recombinant Proteins | 5 | 2026 | 1324 | 0.290 |
Why?
|
| Horses | 3 | 2025 | 93 | 0.270 |
Why?
|
| Immunization, Passive | 2 | 2025 | 122 | 0.260 |
Why?
|
| Antibodies, Protozoan | 2 | 2025 | 101 | 0.260 |
Why?
|
| Antigens, Protozoan | 2 | 2024 | 79 | 0.250 |
Why?
|
| Technology | 2 | 2024 | 69 | 0.250 |
Why?
|
| Arecaceae | 2 | 2017 | 2 | 0.240 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2025 | 11 | 0.230 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2023 | 402 | 0.230 |
Why?
|
| Helminth Proteins | 1 | 2026 | 105 | 0.230 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2025 | 55 | 0.230 |
Why?
|
| Metabolome | 2 | 2020 | 326 | 0.220 |
Why?
|
| Feces | 2 | 2026 | 722 | 0.220 |
Why?
|
| Prebiotics | 1 | 2024 | 29 | 0.220 |
Why?
|
| Transfection | 2 | 2024 | 963 | 0.210 |
Why?
|
| Antibody Formation | 1 | 2025 | 227 | 0.210 |
Why?
|
| Ascaris suum | 1 | 2024 | 32 | 0.210 |
Why?
|
| Disease Models, Animal | 6 | 2026 | 4683 | 0.210 |
Why?
|
| Saccharomycetales | 2 | 2021 | 37 | 0.210 |
Why?
|
| Larva | 1 | 2024 | 249 | 0.210 |
Why?
|
| Extracellular Matrix | 1 | 2025 | 235 | 0.210 |
Why?
|
| RNA Caps | 1 | 2024 | 28 | 0.210 |
Why?
|
| Myocarditis | 2 | 2015 | 132 | 0.200 |
Why?
|
| Trypanocidal Agents | 1 | 2023 | 33 | 0.200 |
Why?
|
| Protozoan Proteins | 1 | 2024 | 131 | 0.200 |
Why?
|
| Nitroimidazoles | 1 | 2023 | 48 | 0.200 |
Why?
|
| Tissue Distribution | 1 | 2024 | 364 | 0.200 |
Why?
|
| Parasite Load | 2 | 2020 | 32 | 0.200 |
Why?
|
| Adaptive Immunity | 1 | 2024 | 102 | 0.200 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2024 | 379 | 0.190 |
Why?
|
| Disease Susceptibility | 2 | 2021 | 278 | 0.180 |
Why?
|
| Iron | 1 | 2025 | 305 | 0.180 |
Why?
|
| Molecular Typing | 3 | 2017 | 32 | 0.180 |
Why?
|
| Models, Animal | 1 | 2024 | 454 | 0.180 |
Why?
|
| Colombia | 3 | 2017 | 49 | 0.180 |
Why?
|
| Humans | 21 | 2026 | 130870 | 0.180 |
Why?
|
| Probiotics | 1 | 2024 | 226 | 0.180 |
Why?
|
| Antibodies, Monoclonal | 2 | 2025 | 983 | 0.180 |
Why?
|
| RNA, Protozoan | 1 | 2021 | 10 | 0.180 |
Why?
|
| Sequence Analysis, DNA | 2 | 2026 | 1722 | 0.170 |
Why?
|
| Zebrafish | 1 | 2024 | 423 | 0.170 |
Why?
|
| Nasal Sprays | 1 | 2021 | 7 | 0.170 |
Why?
|
| Oxidative Stress | 1 | 2026 | 797 | 0.170 |
Why?
|
| Immunodominant Epitopes | 1 | 2021 | 46 | 0.170 |
Why?
|
| Tropism | 1 | 2020 | 9 | 0.170 |
Why?
|
| Death, Sudden | 1 | 2021 | 45 | 0.170 |
Why?
|
| NADPH Oxidase 2 | 1 | 2020 | 37 | 0.160 |
Why?
|
| RNA | 1 | 2024 | 520 | 0.160 |
Why?
|
| Computational Biology | 1 | 2026 | 868 | 0.160 |
Why?
|
| Vero Cells | 1 | 2020 | 115 | 0.160 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2026 | 914 | 0.160 |
Why?
|
| Respiratory Mucosa | 1 | 2021 | 93 | 0.160 |
Why?
|
| Gene Expression | 2 | 2021 | 1492 | 0.160 |
Why?
|
| Myocardium | 3 | 2020 | 863 | 0.160 |
Why?
|
| Phylogeny | 3 | 2018 | 693 | 0.160 |
Why?
|
| STAT3 Transcription Factor | 1 | 2021 | 231 | 0.150 |
Why?
|
| Heart | 2 | 2021 | 662 | 0.150 |
Why?
|
| Genome, Protozoan | 1 | 2018 | 26 | 0.140 |
Why?
|
| Transients and Migrants | 2 | 2016 | 29 | 0.140 |
Why?
|
| DNA | 1 | 2024 | 1420 | 0.140 |
Why?
|
| Autoantibodies | 1 | 2021 | 439 | 0.140 |
Why?
|
| HEK293 Cells | 1 | 2020 | 809 | 0.140 |
Why?
|
| Multigene Family | 1 | 2018 | 291 | 0.130 |
Why?
|
| Dendritic Cells | 1 | 2020 | 436 | 0.130 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 464 | 0.130 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2020 | 499 | 0.130 |
Why?
|
| Lymphopoiesis | 1 | 2017 | 9 | 0.130 |
Why?
|
| Thymocytes | 1 | 2017 | 10 | 0.130 |
Why?
|
| Insect Control | 1 | 2017 | 11 | 0.130 |
Why?
|
| Mice, Knockout | 3 | 2020 | 3836 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 977 | 0.130 |
Why?
|
| Thymus Gland | 1 | 2017 | 105 | 0.130 |
Why?
|
| Ecosystem | 1 | 2017 | 91 | 0.120 |
Why?
|
| Protein Domains | 3 | 2021 | 253 | 0.120 |
Why?
|
| Receptors, Prostaglandin E, EP2 Subtype | 1 | 2015 | 7 | 0.120 |
Why?
|
| Cell Line | 1 | 2020 | 2580 | 0.120 |
Why?
|
| Dinoprostone | 1 | 2015 | 65 | 0.110 |
Why?
|
| Arginine | 1 | 2018 | 338 | 0.110 |
Why?
|
| Cyclooxygenase 2 | 1 | 2015 | 121 | 0.110 |
Why?
|
| Interleukin-6 | 1 | 2017 | 413 | 0.110 |
Why?
|
| Base Sequence | 1 | 2018 | 2764 | 0.110 |
Why?
|
| Antibodies, Neutralizing | 3 | 2023 | 522 | 0.100 |
Why?
|
| Genotype | 2 | 2017 | 2606 | 0.100 |
Why?
|
| Trypanosomiasis | 1 | 2013 | 2 | 0.100 |
Why?
|
| Chiroptera | 1 | 2013 | 17 | 0.100 |
Why?
|
| Nebulizers and Vaporizers | 2 | 2025 | 60 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 4 | 2025 | 4716 | 0.100 |
Why?
|
| HIV Infections | 1 | 2024 | 2036 | 0.090 |
Why?
|
| Antibodies, Viral | 3 | 2023 | 1167 | 0.090 |
Why?
|
| B-Lymphocytes | 2 | 2025 | 509 | 0.080 |
Why?
|
| Flow Cytometry | 2 | 2026 | 771 | 0.080 |
Why?
|
| Cell Differentiation | 1 | 2017 | 1935 | 0.070 |
Why?
|
| Female | 11 | 2026 | 70560 | 0.070 |
Why?
|
| Bacterial Proteins | 2 | 2025 | 940 | 0.070 |
Why?
|
| Animals, Newborn | 2 | 2023 | 1019 | 0.070 |
Why?
|
| Liver | 2 | 2026 | 1800 | 0.070 |
Why?
|
| Immune Evasion | 1 | 2026 | 38 | 0.060 |
Why?
|
| Bolivia | 2 | 2016 | 12 | 0.060 |
Why?
|
| Spain | 2 | 2016 | 60 | 0.060 |
Why?
|
| Endemic Diseases | 2 | 2016 | 59 | 0.050 |
Why?
|
| Lung | 2 | 2024 | 1550 | 0.050 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2024 | 110 | 0.050 |
Why?
|
| Hepatomegaly | 1 | 2023 | 22 | 0.050 |
Why?
|
| PPAR alpha | 1 | 2023 | 53 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2021 | 1238 | 0.050 |
Why?
|
| Immunity, Humoral | 1 | 2023 | 73 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2025 | 410 | 0.050 |
Why?
|
| HIV | 1 | 2024 | 177 | 0.050 |
Why?
|
| Alum Compounds | 1 | 2022 | 41 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 1 | 2025 | 418 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2023 | 356 | 0.050 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2024 | 510 | 0.040 |
Why?
|
| Hybridomas | 1 | 2021 | 30 | 0.040 |
Why?
|
| Polyethyleneimine | 1 | 2021 | 10 | 0.040 |
Why?
|
| Vaccines, DNA | 1 | 2021 | 43 | 0.040 |
Why?
|
| Bacteria | 1 | 2024 | 521 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 790 | 0.040 |
Why?
|
| Intestines | 1 | 2024 | 589 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2021 | 157 | 0.040 |
Why?
|
| Drug Carriers | 1 | 2021 | 116 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2021 | 781 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2021 | 218 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2021 | 715 | 0.040 |
Why?
|
| Genes, Protozoan | 1 | 2018 | 25 | 0.040 |
Why?
|
| Transcriptome | 1 | 2025 | 1129 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2025 | 1833 | 0.030 |
Why?
|
| Prevalence | 2 | 2016 | 2694 | 0.030 |
Why?
|
| Lymphoid Progenitor Cells | 1 | 2017 | 2 | 0.030 |
Why?
|
| Plasma | 1 | 2018 | 103 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 2407 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2017 | 120 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2018 | 439 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2021 | 903 | 0.030 |
Why?
|
| Atrophy | 1 | 2017 | 246 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2018 | 1052 | 0.030 |
Why?
|
| Cytochromes b | 1 | 2015 | 5 | 0.030 |
Why?
|
| Population Density | 1 | 2015 | 31 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2021 | 2907 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2017 | 319 | 0.030 |
Why?
|
| Cresols | 1 | 2014 | 10 | 0.030 |
Why?
|
| Sulfuric Acid Esters | 1 | 2014 | 15 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 1215 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 2014 | 21 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 1501 | 0.030 |
Why?
|
| DNA, Helminth | 1 | 2014 | 23 | 0.030 |
Why?
|
| United States | 2 | 2024 | 11865 | 0.030 |
Why?
|
| Coinfection | 1 | 2016 | 188 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 193 | 0.030 |
Why?
|
| Ecology | 1 | 2013 | 13 | 0.030 |
Why?
|
| Trypanosoma | 1 | 2013 | 8 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 153 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2025 | 4697 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2018 | 976 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 1713 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2013 | 222 | 0.020 |
Why?
|
| Biomarkers | 1 | 2021 | 3400 | 0.020 |
Why?
|
| Metabolomics | 1 | 2014 | 506 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 3497 | 0.020 |
Why?
|
| Adult | 3 | 2016 | 31245 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2016 | 1555 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2016 | 5095 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 3807 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 12914 | 0.010 |
Why?
|
| Male | 2 | 2016 | 64772 | 0.010 |
Why?
|
| Middle Aged | 1 | 2014 | 28517 | 0.010 |
Why?
|